Insulin Glulisine in Type 2 Diabetes Mellitus

NCT00310297 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Insulin Glulisine

Sponsor

Sanofi